title: [Changes of cytokine levels in ascitic fluid after intraperitoneal administration of OK-432 or CDDP].
abstract: In order to evaluate the biological response after intraperitoneal administration of OK-432 and CDDP, we studied the changes of cytokine levels in ascitic fluid. A total of 53 gastric cancer patients were included in this study. OK-432 20KE was administered in 7 patients and CDDP was administered in 4 patients intraperitoneally during operation. The IL-6, IL-8, TNF-alpha and sTNF RI levels in ascitic fluid were measured from 0 to 5 postoperative day. These results were compared with those obtained from the control groups (42 patients). The ascitic level of IL-6 increased immediately after operation, then gradually decreased. The elevations of IL-6 from 0 to 5 postoperative day were remarkably higher in the OK-432 treated group, and those on 0 and 1 postoperative days were remarkably lower in CDDP treated group than in the control group. Similarly, the ascitic level of IL-8 elevated soon after operation and then decreased gradually. In the OK-432 treated group, the ascitic level of IL-8 was significantly higher than in the control group from 0 to 2 postoperative day. Ascitic TNF-alpha was detectable only in the ascites soon after operation in the OK-432 treated group. The ascitic level of sTNF RI peaked on 2 postoperative day in the control and the OK-432 treated group and 1 postoperative day in the CDDP treated group. There were no significant differences between these groups.
authors.affiliation: Dept. of Surgery 1, Iwate Medical University.
authors.forename: M
authors.initials: M
authors.lastname: Terashima
authors.forename: A
authors.initials: A
authors.lastname: Takagane
authors.forename: K
authors.initials: K
authors.lastname: Abe
authors.forename: M
authors.initials: M
authors.lastname: Kuboi
authors.forename: H
authors.initials: H
authors.lastname: Asahi
authors.forename: K
authors.initials: K
authors.lastname: Saito
mesh_terms: D000368:Aged; D001202:Ascitic Fluid / Q000276:immunology*; D002945:Cisplatin / Q000008:administration & dosage*; D016207:Cytokines / Q000378:metabolism*; D005260:Female; D005743:Gastrectomy; D006801:Humans; D007263:Infusions, Parenteral; D016209:Interleukin-8 / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010844:Picibanil / Q000008:administration & dosage*; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000601:surgery; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D016207:Cytokines; D016209:Interleukin-8; D014409:Tumor Necrosis Factor-alpha; D010844:Picibanil; D002945:Cisplatin